24-27 November 2026Crocus Expo, Pavilion 2, Moscow
RU
With audit pressure rising and supply chains still uneven, pharmaceutical manufacturers across Russia and the CIS are placing greater weight on data integrity, reliable sourcing, and throughput stability. Pharma 4.0 automation is now central to that discussion, linking equipment performance to quality oversight, batch release speed, and predictable overall equipment effectiveness (OEE). In this context, the Pharmtech Expo serves as a practical reference point: a single location where engineering, QA, R&D, and procurement teams can compare equipment, ingredients, and service providers against current compliance expectations and regional operating realities.
Pharmtech & Ingredients is positioned as the largest sector exhibition in Russia and the EAEU for equipment, raw materials, and technologies supporting pharmaceutical production, alongside adjacent industries such as dietary supplements, veterinary products, blood products, and cosmetics.
This matters because most manufacturing bottlenecks are not isolated to a single function. Yield losses, deviation rates, and delayed release typically sit at the intersection of:
A platform that brings these dependencies together supports faster technical evaluation and more realistic capex or sourcing decisions.
Regulators and quality leaders increasingly expect “right-first-time” systems that are validated, documented, and demonstrably controlled. WHO defines GMP as part of a quality management system intended to support consistent production and control in accordance with required standards, reducing risks such as mix-ups and contamination.
For organisations operating across Eurasia, that baseline interacts with the EAEU (Eurasian Economic Union) framework, where inspections and GMP alignment are increasingly formalised through guidance and risk-based approaches.
In practice, evaluation criteria differ by function, but alignment is essential.
To support structured evaluation, many firms align internal decisions with recognised quality frameworks, such as the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q9 (risk management) and ICH Q10 (pharmaceutical quality system).
Pharmtech & Ingredients is most valuable when treated as a technical discovery environment rather than a brochure-driven exercise. The best outcomes typically come from pre-defined evaluation criteria and cross-functional attendance.
To keep decision-making disciplined, teams can structure the day around pharmaceutical exhibition sectors such as ingredients sourcing, process equipment, cleanroom systems, laboratory instruments, packaging, and serialisation, then link each conversation back to one of three outcomes:
For those tracking developments year-round, monitoring Pharmtech's latest news can help shortlist suppliers and topics before arriving on-site.
A successful plan is simple: define a problem statement, set acceptance criteria, and leave with enough evidence to progress an internal business case. Teams that visit pharma trade shows with a structured brief tend to shorten qualification cycles by handling technical and commercial questions in parallel.
Relevant internal reading for planning and role alignment includes Pharmtech & Ingredients’ articles on automation/packaging/lab systems, as well as on nutraceutical ingredient trends (useful for companies spanning pharma and adjacent categories).
Pharmtech & Ingredients (24–27 November 2026, Crocus Expo, Pavilion 2) brings together decision-makers seeking regulatory-aligned equipment, dependable ingredient sourcing, packaging and serialisation capabilities, and contract manufacturing support at a pharma manufacturing expo.
Interested in exhibiting? Submit an enquiry to reserve your space and connect with pharmaceutical manufacturing decision-makers across Eurasia. These teams are actively assessing suppliers for compliant scale, process stability, and measurable throughput gains.
